European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

18 EU fundings (€12.8M): Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe … BdlYear 2022 EU Research and Innovation programme "Horizon"

Text

The Brønnøysund Register Centre 993467049

26/08/2022 EU funding (€1,457,000): Diabetes, obesity and the Kidney
16/09/2022 EU funding (€1,500,000): Final act of the autophagy symphony: Whole-organism orchestration of autophagy termination
04/09/2022 EU funding (€10.3M): Psych-STRATA - A Stratified Treatment Algorithm in Psychiatry: A program on stratified pharmacogenomics in severe mental illness
29/12/2022 EU funding (€10.6M): Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe
01/07/2022 EU funding (€12.4M): eBRAIN-Health - Actionable Multilevel Health Data
05/08/2022 EU funding (€12M): A clinical research network to improve the management of Monkeypox virus disease
04/09/2022 EU funding (€2,734,402): Combination therapy for the treatment of metastatic melanoma using magnetic nanoparticles
01/02/2022 EU funding (€21M): Integrated Services for Infectious Disease Outbreak Research
12/08/2022 EU funding (€284,180): Guiding glioblastoma treatments by decrypting tumor biomechanics via Magnetic Resonance Elastography.
30/09/2022 EU funding (€3,337,725): Supervised morphogenesis in gastruloids
02/08/2022 EU funding (€4,674,996): OPTIMISING COLORECTAL CANCER PREVENTION TROUGH PERSONALISED TREATMENT WITH ARTIFICIAL INTELLIGENCE
01/09/2022 EU funding (€4,773,470): Developing and implementing innovative Patient-Centred Care Pathways for cancer patients
03/08/2022 EU funding (€4,883,229): Implementing a patient-centred and evidence-based intervention to reduce BEnzodiazepine and sedative-hypnotic use to improve patient SAFEty and quality of care
01/07/2022 EU funding (€6,393,734): Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology
01/08/2022 EU funding (€7,984,441): Dual screening by Spectral Artificial Visual Examination (SAVE) for Female Genital Schistosomiasis (FGS) and cervical cancer. Digital, new, low-cost, and simple screening and training.
28/07/2022 EU funding (€8,190,468): Intelligent Ecosystem to improve the governance, the sharing and the re-use of health Data for Rare Cancers
01/06/2022 EU funding (€9,045,288): Reducing the impact of major environmental challenges on mental health
29/11/2022 EU funding (€9,197,628): Maximising Impact of Prescription Drugs in Rheumatoid Arthritis
CSV export

Quarterly Exports in CSV

Now available in CSV format and optimized for applications in AI and Analytics:
North Data's quarterly exports have become the industry standard for company information.

This filing was translated from to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Oslo Universitetssykehus HF, Oslo, Norway.

Printing is only available to North Data premium service subscribers.